Nausea News and Research

RSS

Nausea is the sensation of unease and discomfort in the upper stomach and head with an urge to vomit. An attack of nausea is known as a qualm.

The medical use of marijuana

The medical use of marijuana enjoys wide public support. More than 70% of respondents to recent surveys agree that marijuana should be available medically. Sources: Pew Research Center for the People & the Press conducted by Princeton Survey Research Associates. Feb. 14-19, 2001 and The Gallup Poll. March 19-21, 1999.

30 Jun 2004

Health Canada warning for health products containing Star Anise unless it is identified as Chinese Star Anise

As a precautionary measure, Health Canada is advising Canadian consumers not to ingest herbal teas or health products containing the herb "star anise"

29 Jun 2004

U.S. Supreme Court to decide whether anti-drug laws should apply to the medicinal use of marijuana

The U.S. Supreme Court is to decide whether anti-drug laws should apply to the medicinal use of marijuana.

29 Jun 2004

Duloxetine reduces stress urinary incontinence and improves quality of life for women

Data presented today at the 3rd International Consultation on Incontinence, provide evidence for the efficacy of duloxetine, an investigational agent for the treatment of women with stress urinary incontinence (SUI).

29 Jun 2004

Opuntia ficus indica, a type of prickly pear cactus reduces hangover symptoms

Everyone knows a sure the way to avoid a hangover is to abstain from drinking alcoholic beverages, or at least to drink without over-indulging.

29 Jun 2004

Alzheimer’s Society expresses concern over new study on dementia drug effectiveness, published in The Lancet

The Alzheimer’s Society has expressed serious concern at the interpretation of a new study into the effectiveness of drugs for dementia, published in The Lancet.

25 Jun 2004

Possible association between the cholesterol lowering drug Crestor, and a serious condition called rhabdomyolysis

Health Canada is advising Canadians about a possible association between the cholesterol lowering drug Crestor®, and a serious condition called rhabdomyolysis.

23 Jun 2004

UK Rates of acute pancreatitis have doubled over the past 30 years

Rates of acute pancreatitis (inflammation of the pancreas) have doubled over the past 30 years, particularly among younger age groups, finds a study in this week's BMJ.

17 Jun 2004

Support for the medical use of marijuana

Manhattan District Attorney Robert M. Morgenthau has announced his support for the medical use of marijuana. The District Attorney was joined by Montel Williams in announcing support for legislation introduced by New York State Assemblyman Richard Gottfried.

16 Jun 2004

Results from study of Rituxan in rheumatoid arthritis show promise

Genentech, Inc., Biogen Idec and Roche have announced that the New England Journal of Medicine published the results of a Phase IIa study showing that two doses of Rituxan® (Rituximab), administered two weeks apart, improved symptoms in patients with moderate-to-severe rheumatoid arthritis (RA) for up to 48 weeks when combined with methotrexate (MTX), compared to MTX alone.

16 Jun 2004

Continuing problems with high levels of pesticide residues in fruits popular with children

New pesticide residue results reveal continuing problems with high levels of pesticide residues in fruits popular with children, including apples, pears and grapes. But processed baby food is completely residue free.

11 Jun 2004

Arizona advisory on tick removal

As hotter temperatures draw Arizonans to the state’s high country, Department of Health Services Director Catherine Eden advised residents to take precautions against tick bites because some ticks carry germs that cause disease, including Rocky Mountain spotted fever.

11 Jun 2004

Docetaxel decreases the chance of dying by 24 percent in advanced-stage prostate cancer patients resistant to hormone therapy

Johns Hopkins Kimmel Cancer Center clinicians were among those at leading institutions that have completed a three-year international study showing that docetaxel, a drug made from yew tree needles, decreases the chance of dying by 24 percent in advanced-stage prostate cancer patients resistant to hormone therapy.

11 Jun 2004

America's first two WNV encephalitis cases of 2004 respond to treatment

GenoMed, Inc. has announced that the country's second case of West Nile virus encephalitis has responded promptly to its treatment approach. So far, GenoMed's treatment is showing a 100% response rate among 13 immunocompetent patients. The sooner the treatment is instituted, the more rapid and more complete the response.

10 Jun 2004

Drug may benefit patients suffering deep scarring after radiation treatment

Cancer patients who suffer from a progressive, deep scarring of tissue following radiation treatment might benefit from a drug that’s FDA-approved to treat vascular disease, according to a University of Rochester study published in this month’s Journal of Clinical Oncology.

10 Jun 2004

Genetic link between hormones and migraine

Director of the Genomics Research Centre Professor Lyn Griffiths and her team of researchers at Griffith University have identified a genetic link between hormones and migraine.

9 Jun 2004

Alfalfa sprouts recalled due to possible health risk

The Food and Drug Administration has been alerted that Sprouters Northwest, Inc. of Kent Washington is recalling 2, 3, and 5 lbs. institutional trays of its raw alfalfa sprouts sent to various food institutions because they may be linked to a recent increase in Salmonellosis in Oregon and Washington State.

5 Jun 2004

Exenatide shows significant improvements in glucose control for people With type 2 diabetes

Amylin Pharmaceuticals, Inc., and Eli Lilly and Company have presented detailed 30-week data from two of the three pivotal Phase 3 studies of exenatide during a late-breaking session at the American Diabetes Association's (ADA) 64th Scientific Sessions in Orlando, Florida.

5 Jun 2004

Drug Tarceva improves survival chance for patients with advanced lung cancer

Roche OSI Pharmaceuticals and Genentech today announced that their investigational drug Tarceva(TM) (erlotinib) achieved a significant 42.5% improvement in median survival compared to placebo in patients with advanced non-small cell lung cancer (NSCLC).

5 Jun 2004

New generation drug therapy targets the individual

The days of ‘one size fits all’ medicines may soon be a thing of the past for people undergoing radical drug therapies for chronic or serious illnesses.

5 Jun 2004

Nausea News and Research

Further Reading

The medical use of marijuana

Health Canada warning for health products containing Star Anise unless it is identified as Chinese Star Anise

U.S. Supreme Court to decide whether anti-drug laws should apply to the medicinal use of marijuana

Duloxetine reduces stress urinary incontinence and improves quality of life for women

Opuntia ficus indica, a type of prickly pear cactus reduces hangover symptoms

Alzheimer’s Society expresses concern over new study on dementia drug effectiveness, published in The Lancet

Possible association between the cholesterol lowering drug Crestor, and a serious condition called rhabdomyolysis

UK Rates of acute pancreatitis have doubled over the past 30 years

Support for the medical use of marijuana

Results from study of Rituxan in rheumatoid arthritis show promise

Continuing problems with high levels of pesticide residues in fruits popular with children

Arizona advisory on tick removal

Docetaxel decreases the chance of dying by 24 percent in advanced-stage prostate cancer patients resistant to hormone therapy

America's first two WNV encephalitis cases of 2004 respond to treatment

Drug may benefit patients suffering deep scarring after radiation treatment

Genetic link between hormones and migraine

Alfalfa sprouts recalled due to possible health risk

Exenatide shows significant improvements in glucose control for people With type 2 diabetes

Drug Tarceva improves survival chance for patients with advanced lung cancer

New generation drug therapy targets the individual

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News